Mast cells in endometriosis: guilty or innocent bystanders?
- PMID: 22332753
- DOI: 10.1517/14728222.2012.661415
Mast cells in endometriosis: guilty or innocent bystanders?
Abstract
Endometriosis (EMS) is a chronic, estrogen-dependent inflammatory disease characterized by growth of endometrial tissue outside the uterine cavity. Symptoms in EMS patients include severe pelvic pain, dysmenorrhea, dyspareunia and infertility. To date, medical therapies are mostly based on hormonal suppressive drugs that induce a hypoestrogenic state. Although being effective regarding the reduction of endometriotic tissue masses and pelvic pain, this treatment is accompanied by severe side effects. Since EMS is associated with chronic inflammation, novel therapeutic strategies also focus on immune modulating drugs. However, little is known about how and to what extent immune cell subsets contribute to the network of locally produced cytokines, chemokines and other mitogenic factors that modulate the growth of ectopic endometrial implants and the inflammation associated with them. Mast cells (MCs) are known to be key players of the immune system, especially during allergic reactions. However, in recent years MCs have been identified to exhibit a far broader range of functions and to be involved in host defense and wound healing responses. Here, recent reports that imply an involvement of MCs in EMS has been reviewed, while the value of novel mouse models for clarifying their contribution to the pathology of this condition has been discussed.
Similar articles
-
Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1.Am J Reprod Immunol. 2007 Aug;58(2):75-97. doi: 10.1111/j.1600-0897.2007.00502.x. Am J Reprod Immunol. 2007. PMID: 17631002 Review.
-
Anomalies in the inflammatory response in endometriosis and possible consequences: a review.Minerva Endocrinol. 2012 Mar;37(1):75-92. Minerva Endocrinol. 2012. PMID: 22382616 Review.
-
Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology.Front Immunol. 2022 Aug 9;13:961599. doi: 10.3389/fimmu.2022.961599. eCollection 2022. Front Immunol. 2022. PMID: 36016927 Free PMC article.
-
Emerging drugs for endometriosis.Expert Opin Emerg Drugs. 2004 May;9(1):167-77. doi: 10.1517/eoed.9.1.167.32945. Expert Opin Emerg Drugs. 2004. PMID: 15155142 Review.
-
Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues.Lab Invest. 2016 Sep;96(9):959-971. doi: 10.1038/labinvest.2016.74. Epub 2016 Jun 27. Lab Invest. 2016. PMID: 27348627 Free PMC article.
Cited by
-
Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation.J Biol Eng. 2024 Jul 26;18(1):42. doi: 10.1186/s13036-024-00437-0. J Biol Eng. 2024. PMID: 39061076 Free PMC article.
-
Association of endometriosis with Sjögren's syndrome: Genetic insights (Review).Int J Mol Med. 2024 Feb;53(2):20. doi: 10.3892/ijmm.2024.5344. Epub 2024 Jan 8. Int J Mol Med. 2024. PMID: 38186322 Free PMC article. Review.
-
Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review.Front Rehabil Sci. 2023 Apr 28;4:1122673. doi: 10.3389/fresc.2023.1122673. eCollection 2023. Front Rehabil Sci. 2023. PMID: 37234076 Free PMC article. Review.
-
GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain via the production of FGF2.Front Immunol. 2023 Feb 8;14:1106771. doi: 10.3389/fimmu.2023.1106771. eCollection 2023. Front Immunol. 2023. PMID: 36845134 Free PMC article.
-
Association of endometriosis with cardiovascular disease: Genetic aspects (Review).Int J Mol Med. 2023 Mar;51(3):29. doi: 10.3892/ijmm.2023.5232. Epub 2023 Feb 17. Int J Mol Med. 2023. PMID: 36799179 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical